Australia's Osteopore surges 200% before trading halt

Osteopore

23/04/2024 04:15

** Shares of Osteopore  OSX.AX  rise as much as 233.3% to
A$0.550, their highest since March 27
    ** Stock posts its biggest intraday percentage gain since
March 27
    ** Trading in shares of medical equipment supplier on halt
pending an announcement on an ASX price and volume aware query
    ** Co announces commencement of first-in-human clinical
trials for use of its bone-healing drug Heparan Sulphate 3 for
knee preservation in Singapore
    ** About 1.7 mln shares change hands, compared with the
30-day average volume of 255,640
    ** Stock up 39.8% YTD, based on last close



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))